Bharat Biotech also betting big on its intranasal Covid vaccine

Even as the country’s first indigenous Covid-19 vaccine Covaxin has received Emergency Use Authorisation (EUA) from the country’s drug regulatory authorities, its developer Bharat Biotech chairman and managing director Dr Krishna Ella is also very gung-ho about another vaccine candidate – an intranasal Covid-19 vaccine under development.